UMC Governing Board Audit & Finance Committee
Summary
Income from ops below budget YTD by $2.9M; LOS high at 7.11 days.
What Matters to Employees 3 items
$130M in outstanding federal supplemental payments.
Adds Medicare Advantage and Anesthesia fee schedule.
Continued reliance on locum tenens coverage.
All Agenda Items 17 items
Revenue $7.8M above budget; SWB $7.4M above budget.
Revenue $12.5M over budget, expenses $9.5M over; YTD ops income $2.9M below budget.
No exceptions or control deficiencies.
COVID emergency expires May 11; seeking more GME slots.
Two of four goals not met: income from ops and ALOS.
New Medicaid MCO contract for 2024 exchange.
Expenses increased by $2.7M from preliminary budget.
Adds Ortho and Anesthesia to marketplace product.
Extends term through 2025, updates business name.
Medicare Advantage access to specialist services.
Extends term through 2025, updates business name.
Commercial plan adds Ortho and Anesthesia.
New purchase commitment for 90% of radiopharmaceutical products.
Medicaid plan for Specialty Clinic Anesthesia and Ortho.
3-year licensing subscription for email security and archiving.
Increased funding for materials and travel cost increases.
Increased funding due to unforeseen service needs.